Gilead Sciences (GILD) Inventory (2009 - 2026)

Gilead Sciences has reported Inventory for 18 years, with the latest figure at $1.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 8.81% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 8.81% YoY), and the FY2025 full-year result was $1.8 billion, up 3.74% from the prior year.
• Inventory for Q1 2026 stood at $1.9 billion, up from $1.8 billion in the prior quarter.
• The five-year high for Inventory was $2.0 billion in Q2 2024, with the low at $1.5 billion in Q3 2022.
• Historically, Inventory has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2025.
• Annual changes were most pronounced in 2022 — Inventory retreated 16.69% — and 2024, when it climbed 24.07%.
• Gilead Sciences' Inventory stood at $1.5 billion in 2022, then rose by 18.58% to $1.8 billion in 2023, then retreated by 4.31% to $1.7 billion in 2024, then rose by 3.74% to $1.8 billion in 2025, then gained by 7.89% to $1.9 billion in 2026.
• The last three Inventory figures came in at $1.9 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.